180 related articles for article (PubMed ID: 26214190)
1. Sustained delivery of bioactive neurotrophin-3 to the injured spinal cord.
Elliott Donaghue I; Tator CH; Shoichet MS
Biomater Sci; 2015 Jan; 3(1):65-72. PubMed ID: 26214190
[TBL] [Abstract][Full Text] [Related]
2. Enhanced neurotrophin-3 bioactivity and release from a nanoparticle-loaded composite hydrogel.
Stanwick JC; Baumann MD; Shoichet MS
J Control Release; 2012 Jun; 160(3):666-75. PubMed ID: 22510446
[TBL] [Abstract][Full Text] [Related]
3. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury.
Piantino J; Burdick JA; Goldberg D; Langer R; Benowitz LI
Exp Neurol; 2006 Oct; 201(2):359-67. PubMed ID: 16764857
[TBL] [Abstract][Full Text] [Related]
4. Local Delivery of Neurotrophin-3 and Anti-NogoA Promotes Repair After Spinal Cord Injury.
Elliott Donaghue I; Tator CH; Shoichet MS
Tissue Eng Part A; 2016 May; 22(9-10):733-41. PubMed ID: 27056081
[TBL] [Abstract][Full Text] [Related]
5. Injectable intrathecal delivery system for localized administration of EGF and FGF-2 to the injured rat spinal cord.
Jimenez Hamann MC; Tator CH; Shoichet MS
Exp Neurol; 2005 Jul; 194(1):106-19. PubMed ID: 15899248
[TBL] [Abstract][Full Text] [Related]
6. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury.
Baumann MD; Kang CE; Tator CH; Shoichet MS
Biomaterials; 2010 Oct; 31(30):7631-9. PubMed ID: 20656347
[TBL] [Abstract][Full Text] [Related]
7. Novel intrathecal delivery system for treatment of spinal cord injury.
Jimenez Hamann MC; Tsai EC; Tator CH; Shoichet MS
Exp Neurol; 2003 Aug; 182(2):300-9. PubMed ID: 12895441
[TBL] [Abstract][Full Text] [Related]
8. Localized and sustained delivery of fibroblast growth factor-2 from a nanoparticle-hydrogel composite for treatment of spinal cord injury.
Kang CE; Baumann MD; Tator CH; Shoichet MS
Cells Tissues Organs; 2013; 197(1):55-63. PubMed ID: 22796886
[TBL] [Abstract][Full Text] [Related]
9. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection.
Tsai EC; Dalton PD; Shoichet MS; Tator CH
Biomaterials; 2006 Jan; 27(3):519-33. PubMed ID: 16099035
[TBL] [Abstract][Full Text] [Related]
10. Click-crosslinked injectable hyaluronic acid hydrogel is safe and biocompatible in the intrathecal space for ultimate use in regenerative strategies of the injured spinal cord.
Führmann T; Obermeyer J; Tator CH; Shoichet MS
Methods; 2015 Aug; 84():60-9. PubMed ID: 25846399
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal drug delivery strategy is safe and efficacious for localized delivery to the spinal cord.
Shoichet MS; Tator CH; Poon P; Kang C; Baumann MD
Prog Brain Res; 2007; 161():385-92. PubMed ID: 17618992
[TBL] [Abstract][Full Text] [Related]
12. A new paradigm for local and sustained release of therapeutic molecules to the injured spinal cord for neuroprotection and tissue repair.
Kang CE; Poon PC; Tator CH; Shoichet MS
Tissue Eng Part A; 2009 Mar; 15(3):595-604. PubMed ID: 18991489
[TBL] [Abstract][Full Text] [Related]
13. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury.
Taylor SJ; Rosenzweig ES; McDonald JW; Sakiyama-Elbert SE
J Control Release; 2006 Jul; 113(3):226-35. PubMed ID: 16797770
[TBL] [Abstract][Full Text] [Related]
14. Sustained release of neurotrophin-3 via calcium phosphate-coated sutures promotes axonal regeneration after spinal cord injury.
Hanna A; Thompson DL; Hellenbrand DJ; Lee JS; Madura CJ; Wesley MG; Dillon NJ; Sharma T; Enright CJ; Murphy WL
J Neurosci Res; 2016 Jul; 94(7):645-52. PubMed ID: 27015737
[TBL] [Abstract][Full Text] [Related]
15. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord.
Gupta D; Tator CH; Shoichet MS
Biomaterials; 2006 Apr; 27(11):2370-9. PubMed ID: 16325904
[TBL] [Abstract][Full Text] [Related]
16. An injectable drug delivery platform for sustained combination therapy.
Baumann MD; Kang CE; Stanwick JC; Wang Y; Kim H; Lapitsky Y; Shoichet MS
J Control Release; 2009 Sep; 138(3):205-13. PubMed ID: 19442692
[TBL] [Abstract][Full Text] [Related]
17. An In Situ Gelling Drug Delivery System for Improved Recovery after Spinal Cord Injury.
Liu D; Jiang T; Cai W; Chen J; Zhang H; Hietala S; Santos HA; Yin G; Fan J
Adv Healthc Mater; 2016 Jun; 5(12):1513-21. PubMed ID: 27113454
[TBL] [Abstract][Full Text] [Related]
18. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model.
Taylor SJ; Sakiyama-Elbert SE
J Control Release; 2006 Nov; 116(2):204-10. PubMed ID: 16919351
[TBL] [Abstract][Full Text] [Related]
19. Combined use of spinal cord-mimicking partition type scaffold architecture and neurotrophin-3 for surgical repair of completely transected spinal cord in rats.
Wang X; Li Y; Gao Y; Chen X; Yao J; Lin W; Chen Y; Liu J; Yang Y; Wang X
J Biomater Sci Polym Ed; 2013; 24(8):927-39. PubMed ID: 23647249
[TBL] [Abstract][Full Text] [Related]
20. An injectable heparin-Laponite hydrogel bridge FGF4 for spinal cord injury by stabilizing microtubule and improving mitochondrial function.
Wang C; Gong Z; Huang X; Wang J; Xia K; Ying L; Shu J; Yu C; Zhou X; Li F; Liang C; Chen Q
Theranostics; 2019; 9(23):7016-7032. PubMed ID: 31660084
[No Abstract] [Full Text] [Related]
[Next] [New Search]
